Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Travere Therapeutics Inc
(NQ:
TVTX
)
9.100
+0.200 (+2.25%)
Streaming Delayed Price
Updated: 9:55 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Travere Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Expert Ratings For Travere Therapeutics
August 02, 2024
Via
Benzinga
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
July 27, 2024
Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
July 09, 2024
Via
Benzinga
Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
May 07, 2024
Via
Benzinga
Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
April 17, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights
March 13, 2024
Via
Benzinga
Deep Dive Into Travere Therapeutics Stock: Analyst Perspectives (7 Ratings)
February 16, 2024
Via
Benzinga
TVTX Stock Earnings: Travere Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 06, 2024
TVTX stock results show that Travere Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Earnings Preview For Travere Therapeutics
February 14, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Travere Therapeutics
January 18, 2024
Via
Benzinga
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...
Via
Benzinga
Exposures
Product Safety
Where Travere Therapeutics Stands With Analysts
December 15, 2023
Via
Benzinga
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Travere Therapeutics Stock?
December 05, 2023
Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday.
Via
Benzinga
Crude Oil Moves Lower; AutoZone Profit Tops Views
December 05, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via
Benzinga
Where Travere Therapeutics Stands With Analysts
November 20, 2023
Via
Benzinga
Preview: Travere Therapeutics's Earnings
November 06, 2023
Via
Benzinga
Expert Ratings for Travere Therapeutics
September 22, 2023
Via
Benzinga
NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday
December 05, 2023
U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday
September 22, 2023
Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. Splunk shares fell 0.1% to $144.25 in...
Via
Benzinga
Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges
September 21, 2023
William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX)
Via
Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via
Benzinga
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
September 21, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.